Bridgefront Capital, LLC Uni Qure N.V. Transaction History
Bridgefront Capital, LLC
- $236 Million
- Q2 2024
A detailed history of Bridgefront Capital, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 13,519 shares of QURE stock, worth $66,648. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,519
Previous 23,681
42.91%
Holding current value
$66,648
Previous $123,000
51.22%
% of portfolio
0.03%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding QURE
# of Institutions
141Shares Held
33.7MCall Options Held
1.54MPut Options Held
389K-
Vestal Point Capital, LP New York, NY4.75MShares$23.4 Million1.59% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.65MShares$13.1 Million0.79% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$9.49 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.9MShares$9.37 Million0.78% of portfolio
-
Schroder Investment Management Group London, X01.74MShares$8.58 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $230M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...